Upstart (UPST) — SBC-Corrected Valuation Update, Post-Q2 2026

1. Q2 2026: Operational Bull Case Confirmed

Q2 (reported Aug 4) was the strongest print of 2026 and settled the central question of the year — whether Q1's 13% adjusted EBITDA margin was the trough. It was. Stock rallied approximately 12.6% after hours to $34.14 from $26.50.

Take rate check: $364.7M revenue on $4,227M originations = 8.63%, versus approximately 9.5% blended in FY2025. Compression is real — driven by mix shift toward auto, HELOC, and prime — but slower than feared, and volume growth (+50%) overwhelmed it this quarter.

2. The Monthly Telemetry (New Disclosure Regime)

Upstart now publishes monthly origination volume and its Upstart Macro Index (UMI). The August 3 release is the first soft data point of Q3: July originations of $1,397.4M over 27.4 origination days = $51.0M/day, down 8.1% from June's $55.5M/day and 5.4% below the Q2 average of $53.9M/day. UMI rose to 1.50, the highest since January 2026, meaning models estimate credit losses approximately 50% above a normal economy. Rising UMI mechanically tightens approvals — the July volume dip and the UMI uptick are the same event observed twice. Q3 has opened below the Q2 run rate; the reaffirmed $1.4B guide requires H2 re-acceleration.

3. Macro Regime: Why Rates Flipped the Model

The 2026 Fed narrative moved from expected cuts to hike risk: the latest dot plot shows at least one hike penciled in for 2026, with 2026 PCE inflation projected at 3.6% amid the energy-price shock. This hits UPST through three channels simultaneously: (1) volume — higher consumer rates reduce conversion; (2) take rate — loan buyers demand more yield, compressing UPST's economics; (3) discount rate — long-duration growth equity de-rates. Our WACC moves from 13.5% to 14.0% (risk-free 4.0%, stagflation-adjusted ERP 5.75%, levered beta 2.1, near-zero-coupon convertible debt).

4. The SBC Problem — Where the Equity Value Actually Lives

FY2025: adjusted EBITDA $230M, GAAP net income $54M. The wedge is mostly SBC (approximately $165M, about 16% of revenue) plus D&A. Q2 2026 repeats the pattern: $76.9M adjusted EBITDA against roughly $15M GAAP net income implies the SBC+D&A wedge still runs approximately $60M per quarter — SBC tracking $180–200M annualized, approximately 13% of revenue. Owner FCF = adjusted EBITDA minus SBC minus capex minus cash taxes. Every scenario below applies this definition.

Partial offset: the board authorized a $400M buyback; $278M was deployed by mid-February (including a $100M tranche at an average $31.31), leaving $122M. At full deployment the program retires roughly 13M shares — approximately 1.5 to 2 years of SBC issuance — which makes a flat diluted share count (98M) a credible assumption rather than an optimistic one. The buyback converts SBC from a per-share value leak into a pure P&L expense; it does not make the expense disappear.

5. Three-Scenario DCF (SBC-Corrected, WACC 14%)

EV-to-equity bridge: net debt approximately $625M ($690M 0% converts due 2032 at $82.50 conversion + $425M 1% converts due 2030 at $91.99, less approximately $490M cash), 98M diluted shares held flat (buyback offsets SBC issuance). Capex 2% of revenue, cash tax 21% on positive pre-tax owner earnings.

6. Management's Blueprint, Valued Under Three Lenses

Management targets a 35% revenue CAGR for 2025–2028 (to approximately $2.58B) with a terminal adjusted EBITDA margin of about 25%. Taking that blueprint entirely at face value:

We handicap joint delivery of both the growth and margin targets at approximately 25% (the two are correlated — both require a cooperative macro). The punchline: even full delivery is worth $21–28 under strict SBC accounting. At $34 post-earnings, the market is paying the street lens for the blueprint. The equity story is not the CAGR — it is whether SBC as a percentage of revenue falls faster than take rates compress.

7. Funding Side: Fully De-Risked

The August Castlelake agreement — up to $4B of consumer loan purchases over up to 24 months via forward flow, the fourth and largest deal with this buyer since 2023 — caps a 2026 series (Eltura/Aperture $1B, Centerbridge $1.2B, Fortress $1.25B, Neuberger $600M renewal). A repeat buyer quadrupling its commitment after living with UPST vintages through 2023–2025 is revealed preference on credit quality, and the 24-month tenor removes annual renegotiation risk. But sized against an approximately $17B annualized origination pace, it covers roughly a quarter of volume per year — and pricing is never disclosed. Funding capacity is no longer the constraint on this story; funding economics are, and they show up in the take rate, not the headlines.

8. Verdict

Key risks to our bearish valuation stance: a Fed pivot in 2027 re-rating long-duration fintech; SBC discipline arriving faster than modeled (headcount grew 18% while revenue grew 64% in FY2025 — the leverage exists); UMI declining, which would loosen approvals and re-accelerate volume; and reflexivity — a higher stock price makes the convertibles equity-like and the buyback more powerful.

Sources: Upstart Q2 2026 press release and Q4 2025 press release (ir.upstart.com), upstart.com/volume and upstart.com/umi monthly disclosures, Upstart 8-K filings (Feb 19, 2026 repurchase), Castlelake agreement announcement (Aug 2026), Federal Reserve Summary of Economic Projections. Figures for 2027 and beyond are our estimates. This report is for informational and educational purposes only and is not investment advice. The author may hold positions in securities discussed. All valuations rest on assumptions that may prove incorrect.